Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$638M |
| 2 |
Home Depot
HD
|
+$562M |
| 3 |
Costco
COST
|
+$529M |
| 4 |
AbbVie
ABBV
|
+$493M |
| 5 |
Caterpillar
CAT
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$777M |
| 2 |
CELG
Celgene Corp
CELG
|
+$581M |
| 3 |
Booking.com
BKNG
|
+$579M |
| 4 |
Crown Castle
CCI
|
+$495M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$455M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Financials | 12.8% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALD
351
DELISTED
Callidus Software, Inc.
CALD
| $27.8M | 0.03% |
971,069
-11,064
| -1% | -$302K |
|
352
Renasant Corp
RNST
$4B
| $27.6M | 0.03% |
675,109
+137,791
| +26% | +$5.75M |
|
|
HMHC
353
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $27.4M | 0.03% |
2,948,145
+403,148
| +16% | +$4.02M |
|
|
EXAS
354
DELISTED
Exact Sciences
EXAS
| $27.2M | 0.03% |
518,589
+374,078
| +259% | +$20M |
|
|
PRTY
355
DELISTED
Party City Holdco Inc.
PRTY
| $27.2M | 0.03% |
1,951,404
-4,919
| -0.3% | -$60.5K |
|
356
Cinemark Holdings
CNK
$3.93B
| $27.2M | 0.03% |
780,931
-3,268,075
| -81% | -$116M |
|
|
DERM
357
DELISTED
Dermira, Inc.
DERM
| $27M | 0.03% |
972,326
-1,668,414
| -63% | -$44.2M |
|
|
GLDD
358
DELISTED
Great Lakes Dredge & Dock
GLDD
| $26.7M | 0.03% |
4,941,042
+1,083,810
| +28% | +$5.51M |
|
|
BOLD
359
DELISTED
Audentes Therapeutics, Inc
BOLD
| $26.7M | 0.03% |
853,822
+9,762
| +1% | +$268K |
|
|
CBIO
360
Crescent Biopharma
CBIO
$626M
| $26.7M | 0.03% |
15,878
-24
| -0.2% | -$31.7K |
|
361
CoreCivic
CXW
$3.09B
| $26.5M | 0.03% |
1,176,019
+8,108
| +0.7% | +$195K |
|
362
Ovintiv
OVV
$16.6B
| $26.3M | 0.03% |
394,358
+168,282
| +74% | +$9.93M |
|
363
Laureate Education
LAUR
$5.25B
| $26M | 0.03% |
1,918,608
+640,675
| +50% | +$8.39M |
|
|
INXN
364
DELISTED
Interxion Holding N.V.
INXN
| $25.9M | 0.03% |
440,122
-14,410
| -3% | -$798K |
|
365
Neurocrine Biosciences
NBIX
$17.7B
| $25.3M | 0.02% |
325,423
+4,278
| +1% | +$292K |
|
366
MaxLinear
MXL
$5.88B
| $25.2M | 0.02% |
953,709
+103,970
| +12% | +$2.6M |
|
|
PXD
367
DELISTED
Pioneer Natural Resource Co.
PXD
| $24.8M | 0.02% |
143,384
-12,658
| -8% | -$1.95M |
|
368
Teradata
TDC
$2.8B
| $24.7M | 0.02% |
+642,056
| New | +$23M |
|
369
Core Laboratories
CLB
$518M
| $24.4M | 0.02% |
222,695
+7,319
| +3% | +$731K |
|
|
BRKL
370
DELISTED
Brookline Bancorp
BRKL
| $24M | 0.02% |
1,530,972
+625,962
| +69% | +$9.76M |
|
|
DBVT
371
DBV Technologies
DBVT
$823M
| $24M | 0.02% |
97,391
-21,902
| -18% | -$6.33M |
|
|
EQGP
372
DELISTED
EQGP Holdings, LP
EQGP
| $23.6M | 0.02% |
877,764
+65,310
| +8% | +$1.77M |
|
|
EPZM
373
DELISTED
Epizyme, Inc
EPZM
| $23.5M | 0.02% |
1,875,528
+7,867
| +0.4% | +$114K |
|
374
MSC Industrial Direct
MSM
$7.07B
| $23.4M | 0.02% |
242,442
-71,215
| -23% | -$5.95M |
|
|
ABMD
375
DELISTED
Abiomed Inc
ABMD
| $23.2M | 0.02% |
123,539
+24,048
| +24% | +$4.49M |
|
Similar funds
Jennison Associates's Q4 2017 Portfolio in Review
As of Q4 2017, Jennison Associates held 724 positions worth $101B, up 3.7% from $97.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jennison Associates's Q4 2017 filing shows 76 new, 253 increased, 308 reduced and 75 closed positions. Its largest new stake was Block Inc: 2,492,825 shares worth $86.4M. The largest sale was NVIDIA, an estimated $777M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jennison Associates's largest Q4 2017 buy was Block Inc: 2,492,825 shares worth $86.4M.
- Jennison Associates added most to PayPal in Q4 2017, an estimated $638M increase.
- Jennison Associates's biggest Q4 2017 reduction was NVIDIA, cutting an estimated $777M.
- Jennison Associates fully exited Electronic Arts in Q4 2017, selling an estimated $113M.
- Jennison Associates's ten largest holdings make up 27% of its $101B portfolio in Q4 2017.
- Jennison Associates opened 76 new positions and closed 75 in Q4 2017.
- Jennison Associates's portfolio value rose 3.7% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q4 2017, filed 25 Jan 2018.